Related Experiment Video
Updated: Aug 4, 2026
09:24
Optical Screening of Novel Bacteria-specific Probes on Ex Vivo Human Lung Tissue by Confocal Laser Endomicroscopy
Published on: November 29, 2017
Respiratory tract infections. Goals for 1995
The American Journal of Medicine
|June 28, 1985
Summary
By 1995, advancements in diagnosing respiratory infections will use DNA probes and monoclonal antibodies, making sputum cultures obsolete. New antibiotics and vaccines are also key goals for improved respiratory health.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Public Health
Background:
- Respiratory tract infections (RTIs) pose a significant health burden.
- Current diagnostic and therapeutic strategies for RTIs require improvement.
- Anticipated advancements by 1995 aim to enhance prevention, diagnosis, and management of RTIs.
Purpose of the Study:
- To outline key goals for the prevention, diagnosis, and management of RTIs by 1995.
- To identify critical areas for research and development in antimicrobial and vaccine therapies.
- To emphasize the importance of optimizing the use of existing vaccines.
Main Methods:
- Focus on developing novel diagnostic systems utilizing monoclonal antibody techniques and DNA hybridization for microbial identification.
- Envisioning the obsolescence of traditional sputum cultures.
- Proposing the development of clinical algorithms for patient management and hospitalization decisions.
Main Results:
- Anticipated development of new antibiotics targeting resistant bacteria (e.g., methicillin-resistant staphylococci) and broad-spectrum oral beta-lactams.
- Prospects for enhanced antiviral drug spectrum and development of immunomodulators.
- Promising vaccine development for influenza, parainfluenza, respiratory syncytial virus, and Mycoplasma pneumoniae.
Conclusions:
- Achieving 70% utilization of existing inactivated influenza and pneumococcal vaccines is a critical public health goal.
- Successful development and implementation of new diagnostic tools and therapies will revolutionize RTI management.
- A decade-long strategic plan is essential for combating respiratory tract infections effectively.
More Related Videos
Related Concept Videos
01:25Transmission-based Precautions II: Airborne and Protective Environment
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:29Microbiota of the Respiratory Tract
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...